1. Cooke JE, Eirich R, Racine N, Madigan S. Prevalence of posttraumatic and general psychological stress during COVID-19: A rapid review and meta-analysis. Psychiatry Research. 2020;292:113347. doi:10.1016/j.psychres.2020.113347
2. Klaassen Z, Wallis CJD. Addressing Mental Health in Urology Patients: The Time is Now. Eur Urol Focus. 2020;6(6):1137-1139. doi:10.1016/j.euf.2020.08.009
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. (DSM-5). American Psychiatric Association; 2013. doi:10.1176/appi.books.9780890425596
4. Kurlansik SL, Maffei MS. Somatic Symptom Disorder. American Family Physician. 2016;93(1):49-54.
5. Yates WR, Shortridge AB, Forrest JS. Somatic Symptom Disorders. Medscape. Published online April 23, 2019. Accessed July 18, 2022. https://emedicine.medscape.com/article/294908-overview
6. Walker EA, Gelfand A, Katon WJ, et al. Adult health status of women with histories of childhood abuse and neglect. American Journal of Medicine. 1999;107(4):332-339. doi:10.1016/s0002-9343(99)00235-1
7. Paras ML, Murad MH, Chen LP, et al. Sexual Abuse and Lifetime Diagnosis of Somatic Disorders. JAMA. 2009;302(5):550-561. doi:10.1001/jama.2009.1091
8. Harris AM, Orav EJ, Bates DW, Barsky AJ. Somatization increases disability independent of comorbidity. J Gen Intern Med. 2009;24(2):155-161. doi:10.1007/s11606-008-0845-0
9. Fanni E, Castellini G, Corona G, et al. The Role of Somatic Symptoms in Sexual Medicine: Somatization as Important Contextual Factor in Male Sexual Dysfunction. The Journal of Sexual Medicine. 2016;13(9):1395-1407. doi:10.1016/j.jsxm.2016.07.002
10. Holliday KL, Macfarlane GJ, Nicholl BI, Creed F, Thomson W, McBeth J. Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: results from the EPIFUND study. Journal of Psychosomatic Research. 2010;68(5):469-474. doi:10.1016/j.jpsychores.2010.01.024
11. Kato K, Sullivan PF, Pedersen NL. Latent class analysis of functional somatic symptoms in a population-based sample of twins. Journal of Psychosomatic Research. 2010;68(5):447-453. doi:10.1016/j.jpsychores.2010.01.010
12. D’Souza RS, Hooten WM. Somatic Syndrome Disorders. In: StatPearls. StatPearls Publishing; 2022.
13. Tylee A, Gandhi P. The importance of somatic symptoms in depression in primary care. Prim Care Companion J Clin Psychiatry. 2005;7(4):167-176. doi:10.4088/pcc.v07n0405
14. Levenson JL. Somatic symptom disorder: Assessment and diagnosis. In: Post T, ed. UpToDate. UpToDate; 2021. Accessed July 18, 2022. https://www.uptodate.com/contents/somatic-symptom-disorder-assessment-and-diagnosis?topicRef=109552&source=see_link
15. von Gontard A, Vrijens D, Selai C, et al. Are psychological comorbidities important in the aetiology of lower urinary tract dysfunction—ICI-RS 2018? Neurourol Urodyn. 2019;38(Suppl 5):S8-S17. doi:10.1002/nau.24016
16. Sakakibara R, Uchiyama T, Awa Y, et al. Psychogenic urinary dysfunction: a uro-neurological assessment. Neurourol Urodyn. 2007;26(4):518-524. doi:10.1002/nau.20321
17. Sakakibara R, Ito T, Yamamoto T, et al. Depression, Anxiety and the Bladder. Lower Urinary Tract Symptoms. 2013;5(3):109-120. doi:10.1111/luts.12018
18. Sakakibara R, Katsuragawa S. Voiding and storage symptoms in depression/anxiety. Autonomic Neuroscience : Basic & Clinical. 2022;237:102927. doi:10.1016/j.autneu.2021.102927
19. Chen IC, Lee MH, Lin HH, Wu SL, Chang KM, Lin HY. Somatoform disorder as a predictor of interstitial cystitis/bladder pain syndrome: Evidence from a nested case-control study and a retrospective cohort study. Medicine (Baltimore). 2017;96(18):e6304. doi:10.1097/md.0000000000006304
20. Anyasodor MC, Taylor RE, Bewley A, Goulding JMR. Dysaesthetic penoscrotodynia may be a somatoform disorder: results from a two-centre retrospective case series. Clin Exp Dermatol. 2016;41(5):474-479. doi:10.1111/ced.12824
21. Coffman KL. Loin pain hematuria syndrome: a psychiatric and surgical conundrum. Current Opinion in Organ Transplantation. 2009;14(2):186-190. doi:10.1097/mot.0b013e32832a2195
22. Lucas PA, Leaker BR, Murphy M, Neild GH. Loin pain and haematuria syndrome: a somatoform disorder. QJM. 1995;88(10):703-709.
23. Yeh YW, Kuo SC, Chen CY. Urinary tract infection complicated by urine retention presenting as pseudocyesis in a schizophrenic patient. General Hospital Psychiatry. 2012;34(1):101.e9-101.e10. doi:10.1016/j.genhosppsych.2011.06.008
24. French JH, Hameed S. Illness Anxiety Disorder. In: StatPearls . StatPearls Publishing; 2022.
25. Velurajah R, Brunckhorst O, Waqar M, McMullen I, Ahmed K. Erectile dysfunction in patients with anxiety disorders: a systematic review. Int J Impot Res. 2022;34(2):177-186. doi:10.1038/s41443-020-00405-4
26. Chung KH, Liu SP, Lin HC, Chung SD. Bladder pain syndrome/interstitial cystitis is associated with anxiety disorder. Neurourol Urodynam. 2014;33(1):101-105. doi:10.1002/nau.22382
27. Chung SD, Lin HC. Association between chronic prostatitis/chronic pelvic pain syndrome and anxiety disorder: a population-based study. PloS One. 2013;8(5):e64630. doi:10.1371/journal.pone.0064630
28. Fong TW, Reid RC, Parhami I. Behavioral addictions: where to draw the lines? Psychiatric Clinics of North America. 2012;35(2):279-296. doi:10.1016/j.psc.2012.03.001
29. Derbyshire KL, Grant JE. Compulsive sexual behavior: a review of the literature. Journal of Behavioral Addictions. 2015;4(2):37-43. doi:10.1556/2006.4.2015.003
30. Grant JE, Potenza MN, eds. The Oxford Handbook of Impulse Control Disorders. Vol 1. Oxford University Press; 2012. doi:10.1093/oxfordhb/9780195389715.001.0001
31. Black DW, Kehrberg LL, Flumerfelt DL, Schlosser SS. Characteristics of 36 subjects reporting compulsive sexual behavior. Am J Psychiatry. 1997;154(2):243-249. doi:10.1176/ajp.154.2.243
32. Grant JE, Williams KA, Potenza MN. Impulse-control disorders in adolescent psychiatric inpatients: co-occurring disorders and sex differences. J Clin Psychiatry. 2007;68(10):1584-1592. doi:10.4088/jcp.v68n1018
33. Coleman E, Raymond N, McBean A. Assessment and treatment of compulsive sexual behavior. Minnesota Medicine. 2003;86(7):42-47.
34. The Augustine Fellowship. Sex and Love Addicts Anonymous. Augustine Fellowship; 1986.
35. Smith S. Drugs that cause sexual dysfunction. Psychiatry. 2007;6(3):111-114. doi:10.1016/j.mppsy.2006.12.004
36. Facelle TM, Sadeghi-Nejad H, Goldmeier D. Persistent genital arousal disorder: characterization, etiology, and management. The Journal of Sexual Medicine. 2013;10(2):439-450. doi:10.1111/j.1743-6109.2012.02990.x
37. Leiblum S, Brown C, Wan J, Rawlinson L. Persistent sexual arousal syndrome: a descriptive study. The Journal of Sexual Medicine. 2005;2(3):331-337. doi:10.1111/j.1743-6109.2005.20357.x
38. Veeder TA, Leo RJ. Male genital self-mutilation: a systematic review of psychiatric disorders and psychosocial factors. General Hospital Psychiatry. 2017;44:43-50. doi:10.1016/j.genhosppsych.2016.09.003
39. Gaspar SS, Dias JS, Martins F, Lopes TM. Sexual Urological Emergencies. Sexual Medicine Reviews. 2015;3(2):93-100. doi:10.1002/smrj.44
40. Rafique M. Intravesical foreign bodies: review and current management strategies. Urology Journal. 2008;5(4):223-231.
41. Landgren V, Savard J, Dhejne C, et al. Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review. Drugs. 2022;82(6):663-681. doi:10.1007/s40265-022-01696-1
42. Bancroft J, Tennent G, Loucas K, Cass J. The control of deviant sexual behaviour by drugs. I. Behavioural changes following oestrogens and anti-androgens. Br J Psychiatry. 1974;125(586):310-315. doi:10.1192/bjp.125.3.310
43. Cooper AJ. A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Comprehensive Psychiatry. 1981;22(5):458-465. doi:10.1016/0010-440x(81)90034-1
44. Cooper AJ, Sandhu S, Losztyn S, Cernovsky Z. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles. Can J Psychiatry. 1992;37(10):687-693. doi:10.1177/070674379203701003
45. Schober JM, Kuhn PJ, Kovacs PG, Earle JH, Byrne PM, Fries RA. Leuprolide acetate suppresses pedophilic urges and arousability. Arch Sex Behav. 2005;34(6):691-705. doi:10.1007/s10508-005-7929-2
46. Tennent G, Bancroft J, Cass J. The control of deviant sexual behavior by drugs: a double-blind controlled study of benperidol, chlorpromazine, and placebo. Arch Sex Behav. 1974;3(3):261-271. doi:10.1007/bf01541489
47. Wainberg ML, Muench F, Morgenstern J, et al. A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. J Clin Psychiatry. 2006;67(12):1968-1973. doi:10.4088/jcp.v67n1218
48. Sultana T, Sahib Din J. Compulsive Sexual Behavior and Alcohol Use Disorder Treated With Naltrexone: A Case Report and Literature Review. Cureus. 2022;14(6):e25804. doi:10.7759/cureus.25804
49. Carnahan KT, Jha A. Factitious Disorder. In: StatPearls. StatPearls Publishing; 2022.
50. Sousa Filho D de, Kanomata EY, Feldman RJ, Maluf Neto A. Munchausen syndrome and Munchausen syndrome by proxy: a narrative review. Einstein (São Paulo). 2017;15(4):516-521. doi:10.1590/s1679-45082017md3746
51. Weber B, Gokarakonda SB, Doyle MQ. Munchausen Syndrome. In: StatPearls. StatPearls Publishing; 2022.
52. Heimbach D, Brühl P. Urological Aspects of Munchausen’s Syndrome. Eur Urol. 1997;31(3):371-375. doi:10.1159/000474486
53. Penbegul N, Bozkurt Y, Yildirim K, et al. Multiple surgeries due to pneumaturia, cystolithiasis and neurogenic bladder in a case with Munchausen syndrome. Urology Journal. 2014;11(1):1331-1334.
54. Ando T, Nomura T, Sejiyama S ya, et al. Munchausen Syndrome in the Act of Creating and Enacting Macroscopic Hematuria. Urol Int. 2014;93(3):371-372. doi:10.1159/000357919
55. Chew BH, Pace KT, Honey RJD. Munchausen syndrome presenting as gross hematuria in two women. Urology. 2002;59(4):601. doi:10.1016/s0090-4295(01)01608-9
56. Lazarus A, Kozinn WP. Munchausen’s Syndrome with Hematuria and Sepsis: An Unusual Case. Int J Psychiatry Med. 1991;21(1):113-116. doi:10.2190/181a-575b-3b53-wr2p
57. Finne HA, Heal JK. Urological Manifestation of Cryptic Severe Psychiatric Illness. Military Medicine. 2019;184(5-6):e489-e491. doi:10.1093/milmed/usy320
58. Fukuhara S, Kawamura N, Kakuta Y, Imazu T, Hara T, Yamaguchi S. [Case of self mutilation of urethra in a Munchausen’s syndrome patient]. Hinyokika Kiyo. 2007;53(11):829-831.
59. Gluckman GR, Stoller M. Munchausen’s syndrome: Manifestation as renal colic. Urology. 1993;42(3):347-350. doi:10.1016/0090-4295(93)90631-j
60. Reich JD, Hanno PM. Factitious renal colic. Urology. 1997;50(6):858-862. doi:10.1016/s0090-4295(97)00410-x
61. Feldman KW, Feldman MD, Grady R, Burns MW, McDonald R. Renal and urologic manifestations of pediatric condition falsification/Munchausen by proxy. Pediatr Nephrol. 2007;22(6):849-856. doi:10.1007/s00467-007-0431-4
62. Bass C, Halligan P. Factitious disorders and malingering: challenges for clinical assessment and management. The Lancet. 2014;383(9926):1422-1432. doi:10.1016/s0140-6736(13)62186-8
63. Bass C, Wade DT. Malingering and factitious disorder. Pract Neurol. 2019;19(2):96-105. doi:10.1136/practneurol-2018-001950
64. Patterson DC, Grelsamer RP. Approach to the Patient with Disproportionate Pain. Bull Hosp Jt Dis (2013). 2018;76(2):123-132.
65. Jafferany M, Khalid Z, McDonald KA, Shelley AJ. Psychological Aspects of Factitious Disorder. Prim Care Companion CNS Disord. 2018;20(1):17-02229. doi:10.4088/pcc.17nr02229
66. Alozai UU, McPherson PK. Malingering. In: StatPearls. StatPearls Publishing; 2021.
67. Udoetuk S, Dongarwar D, Salihu HM. Racial and Gender Disparities in Diagnosis of Malingering in Clinical Settings. J Racial and Ethnic Health Disparities. 2020;7(6):1117-1123. doi:10.1007/s40615-020-00734-6
68. Boberg M, Jeppesen U, Arnfred S, Nordgaard J. Do we know the mind of others? Suspicion of malingering in emergency psychiatry. Nordic Journal of Psychiatry. Published online June 17, 2022:1-6. doi:10.1080/08039488.2022.2083676
69. Moldwin R. When renal colic is really malingering. Postgraduate Medicine. 1987;82(7):49-52. doi:10.1080/00325481.1987.11700053
70. Maiers TJ, Abramowitz DJ, Pominville R, Myneni AA, Noyes K, Bodkin Iii JJ. Management of genitourinary foreign bodies in a predominantly incarcerated population. The Canadian Journal of Urology. 2020;27(6):10444-10449.
71. Shah O, Assimos DG. Quartz stones: Spurious or iatrogenic? Urology. 2004;64(4):808-809. doi:10.1016/j.urology.2004.05.014
72. Zalewska A, Kondras K, Dziankowska-Bartkowiak B, Cotterill JA, Sysa-Jędrzejowska A. Malingering of Scrotal Dermatitis. Dermatol Psychosom. 2003;4(3):165-167. doi:10.1159/000073995
73. Blitzstein SM. Recognizing and treating conversion disorder. Virtual Mentor. 2008;10(3):158-160. doi:10.1001/virtualmentor.2008.10.3.cprl1-0803
74. Peeling JL, Muzio MR. Conversion Disorder. In: StatPearls. StatPearls Publishing; 2021.
75. Feinstein A. Conversion disorder: advances in our understanding. Canadian Medical Association Journal. 2011;183(8):915-920. doi:10.1503/cmaj.110490
76. Carson AJ, Best S, Postma K, Stone J, Warlow C, Sharpe M. The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study. Journal of Neurology, Neurosurgery & Psychiatry. 2003;74(7):897-900. doi:10.1136/jnnp.74.7.897
77. Frey RJ. Conversion disorder. In: Encyclopedia of Mental Disorders. Accessed July 21, 2022. http://www.minddisorders.com/Br-Del/Conversion-disorder.html#ixzz35zYRNxAA
78. Neurological conversion disorders in childhood. Lancet. 1991;337(8746):889-890. doi:10.1016/0140-6736(91)90211-7
79. Kozlowska K, Nunn KP, Rose D, Morris A, Ouvrier RA, Varghese J. Conversion disorder in Australian pediatric practice. J Am Acad Child Adolesc Psychiatry. 2007;46(1):68-75. doi:10.1097/01.chi.0000242235.83140.1f
80. Cretton A, Brown RJ, LaFrance WC Jr, Aybek S. What Does Neuroscience Tell Us About the Conversion Model of Functional Neurological Disorders? The Journal of Neuropsychiatry and Clinical Neurosciences. 2020;32(1):24-32. doi:10.1176/appi.neuropsych.19040089
81. Spence ND, Pilowsky I, Minniti R. The attribution of affect in pain clinic patients: a psychophysiological study of the conversion process. Int J Psychiatry Med. 1985;15(1):1-11. doi:10.2190/vxub-t0aa-pr6m-2y6g
82. Voon V, Brezing C, Gallea C, et al. Emotional stimuli and motor conversion disorder. Brain. 2010;133(Pt5):1526-1536. doi:10.1093/brain/awq054
83. Akyüz F, Gökalp PG, Erdiman S, Oflaz S, Karşidağ Ç. Conversion Disorder Comorbidity and Childhood Trauma. Noro Psikiyatri Arsivi. 2017;54(1):15-20. doi:10.5152/npa.2017.19184
84. Cascella M, Thompson NS, Muzio MR, Forte CA, Cuomo A. The underestimated role of psychological and rehabilitation approaches for management of cancer pain. A brief commentary. Recenti Progressi in Medicina. 2016;107(8):418-421. doi:10.1701/2332.25064
85. Kiselica AM, Rosen S, Benge JF. Functional neurological symptoms masquerading as Wernicke encephalopathy following bariatric surgery. Proc (Bayl Univ Med Cent). 2019;32(4):607-609. doi:10.1080/08998280.2019.1651149
86. Gaur S. Non-epileptic Seizures versus Frontal Lobe Epilepsy in an Adolescent: A Case Report. Cureus. 2019;11(9):e5732. doi:10.7759/cureus.5732
87. Teodoro T, Oliveira R, Afonso P. Atypical Lyme Neuroborreliosis, Guillain-Barré Syndrome or Conversion Disorder: Differential Diagnosis of Unusual Neurological Presentations. Case Rep Neurol. 2019;11(1):142-147. doi:10.1159/000499901
88. Shields LBE, Alsorogi MS. Herpes Simplex Virus Type 2 Radiculomyelitis Disguised as Conversion Disorder. Case Rep Neurol. 2019;11(1):117-123. doi:10.1159/000499701
89. Parmar V, Roberts N. A Case of Neurological Symptoms and Severe Urinary Retention on a Pediatric Ward: Is this Conversion Disorder? Journal of the Canadian Academy of Child and Adolescent Psychiatry. 2013;22(1):61-63.
90. Gandy H. Commentary on: A Case of Neurological Symptoms and Severe Urinary Retention on a Pediatric Ward: Is this Conversion Disorder? Journal of the Canadian Academy of Child and Adolescent Psychiatry. 2013;22(1):64.
91. Eldawlatly A, Alshathri NA, Binsaleh S, al Saadon A, Alkhawajah NM. Conversion disorder upon emergence from general anesthesia—A case report and review of literature. Saudi J Anaesth. 2021;15(4):441-443. doi:10.4103/sja.sja_118_21
92. Legaspi PSC, Abad Venida ML. Conversion disorder: “an adverse reaction” to watch out for. Dermatologic Clinics. 2008;26(2):239-243. doi:10.1016/j.det.2007.11.008
93. Naqvi R. Evaluation of psychiatric issues in renal transplant setting. Indian J Nephrol. 2015;25(6):321-325. doi:10.4103/0971-4065.165006